Article Text

Download PDFPDF
Review: most selective serotonin reuptake inhibitors lead to adverse events that appear to outweigh the benefits in children

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


 
 Q Are selective serotonin reuptake inhibitors (SSRIs) safe and effective for treating depression in children?

Clinical impact ratings Mental health ★★★★★★☆ Psychiatry ★★★★★★☆ Paediatrics ★★★★★★☆ GP/FP/Primary care ★★★★★★☆

METHODS

Embedded ImageData sources:

Medline, CINAHL, EMBASE/Excerpta Medica, and PsycINFO (to April 2003); Cochrane Library; reference lists; tables of contents; previous systematic reviews; Guideline Development Group information; and written requests to experts.

Embedded ImageStudy selection and assessment:

English language randomised controlled trials (RCTs) or RCTs with English abstracts that compared SSRIs with placebo in children (5–18 y) with depression; had adequate blinding, concealed allocation, and a description of withdrawals; and were published in peer reviewed …

View Full Text

Footnotes

  • For correspondence: Dr C Whittington, University College London, London, UK. c.whittingtonucl.ac.uk

  • Source of funding: no external funding.